Atlas Venture Life Science Advisors

Atlas Venture Life Science Advisors as of Dec. 31, 2021

Portfolio Holdings for Atlas Venture Life Science Advisors

Atlas Venture Life Science Advisors holds 16 positions in its portfolio as reported in the December 2021 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Kymera Therapeutics Common Stock (KYMR) 40.1 $437M 6.9M 63.49
Day One Biopharmaceuticals Common Stock (DAWN) 12.7 $138M 8.2M 16.85
Dyne Therapeutics Common Stock (DYN) 9.8 $106M 8.9M 11.89
Replimune Group Common Stock (REPL) 8.0 $87M 3.2M 27.10
Ikena Oncology Common Stock (IKNA) 5.8 $63M 5.0M 12.54
Generation Bio Common Stock (GBIO) 5.4 $59M 8.3M 7.08
Akero Therapeutics Common Stock (AKRO) 4.3 $47M 2.2M 21.15
Xilio Therapeutics Common Stock (XLO) 4.1 $44M 2.8M 16.00
Aerovate Therapeutics Common Stock (AVTE) 3.4 $37M 3.1M 11.79
AvroBio Common Stock (AVRO) 1.6 $17M 4.5M 3.85
Spero Therapeutics Common Stock (SPRO) 1.5 $17M 1.0M 16.01
Magenta Therapeutics Common Stock 1.4 $15M 3.5M 4.43
Gemini Therapeutics Common Stock 1.4 $15M 5.3M 2.91
F-star Therapeutics Common Stock 0.3 $3.0M 600k 5.02
Cogent Biosciences Common Stock (COGT) 0.2 $1.9M 223k 8.58
Viridian Therapeutics Common Stock (VRDN) 0.2 $1.8M 90k 19.77